BLACK FRIDAY EARLY — BOGO 50% SITEWIDE

What Are Peptide Bioregulators? The Khavinson Science, the Main Peptides, and What the Evidence Shows

By the Ageless Humans editorial team · Updated 2026-11-14 · 6 min read

Peptide bioregulators are very short chains of amino acids, usually 2 to 4, that researchers believe help regulate gene activity in specific tissues. Most come from the work of Russian gerontologist Vladimir Khavinson. The best-known include epitalon (pineal gland), pinealon (brain), and cartalax (cartilage and connective tissue). Selank is often grouped with them but comes from a different lab. The research is intriguing, but it is still early and comes mostly from one research school.

Peptide Bioregulators, Defined in One Minute

A peptide bioregulator is a short peptide, usually 2–4 amino acids long, studied for its ability to support normal function in one tissue or organ. The idea is that each tissue has its own signaling peptides. When those signals fade with age, supplying a matching short peptide may help that tissue keep working the way it should.

This makes bioregulators different from most peptides people hear about. Many popular peptides are longer chains that act on cell-surface receptors, much like hormones. Bioregulators are tiny by comparison, and the leading theory says they work inside the cell. If you're new to the topic, start with our primer on what peptides are and how they work.

Three traits define the category:

  • Very short. Usually di-, tri-, or tetrapeptides (2, 3, or 4 amino acids).
  • Tissue-specific. Each one is linked to a specific organ or system.
  • Regulatory, not replacement. They are studied as signals that support normal cell function, not as building blocks or hormone substitutes.

Where Bioregulators Came From: The Khavinson Research Tradition

Bioregulators grew out of Soviet-era research led by Vladimir Khavinson, which later continued at the St. Petersburg Institute of Bioregulation and Gerontology. Starting in the 1970s, Khavinson and colleagues studied ways to support resilience and recovery in people under heavy physical and environmental stress, including military personnel.

The work came in two phases:

1. Organ extracts (cytomedins). Researchers first isolated peptide mixtures from animal tissues such as the pineal gland, thymus, and brain. Epithalamin, a pineal extract, is the best-known example. 2. Synthetic short peptides. The team then identified short sequences they believed drove the extracts' activity and made them in the lab. Epitalon, for example, is a synthetic tetrapeptide modeled on the pineal extract.

Over several decades, Khavinson's group published a large body of cell, animal, and human research, much of it in Russian-language journals. That history is why bioregulators have a devoted following in longevity circles. It is also why outside scientists treat them with caution: most of the data comes from one school of research, and independent replication has been limited.

How Short Peptides Are Thought to Work

The leading hypothesis is that bioregulators are small enough to enter the cell nucleus and interact with DNA. There they may help switch tissue-specific genes on or off. Standard peptide signaling works differently. Most peptides bind receptors on the cell surface and trigger a chain reaction inside the cell. Khavinson's group proposed a more direct route.

In that model:

  • Short peptides pass through cell and nuclear membranes because of their small size.
  • They bind specific DNA sequences or the histone proteins that package DNA.
  • That binding influences gene expression, helping restore protein production patterns that tend to drift with age.
  • Because the binding is sequence-specific, each peptide is thought to act mainly in its matching tissue.

The model is elegant, and lab studies have reported peptide–DNA interactions and shifts in gene expression. Still, treat it as a working hypothesis. The details have not been broadly confirmed by independent labs, and scientists still debate how much of an orally taken short peptide survives digestion intact.

The Main Bioregulators and What Each Is Studied For

The four names you'll see most are epitalon, pinealon, cartalax, and selank. Each is associated with a different body system.

Epitalon (Ala-Glu-Asp-Gly). This is the flagship Khavinson peptide, modeled on the pineal extract epithalamin. It has been studied for its role in supporting healthy circadian rhythm and melatonin patterns, and for its interaction with telomerase, the enzyme involved in maintaining telomeres. Read the full breakdown in our guide to epitalon benefits.

Pinealon (Glu-Asp-Arg). This tripeptide is associated with the brain and nervous system. Researchers have studied it for supporting neuronal resilience under stress and healthy cognitive function with age. See our deep dive on pinealon benefits.

Cartalax (Ala-Glu-Asp). This tripeptide is linked to cartilage and connective tissue. It has been studied for supporting the normal activity of the cells that maintain joints and connective structures. More in our article on cartalax benefits.

Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro). Selank is the outlier. It is a seven-amino-acid synthetic analog of tuftsin, a naturally occurring immune peptide. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, not by Khavinson's group. It is grouped with bioregulators because it is a short Russian-developed regulatory peptide, studied for supporting a calm mood, stress resilience, and focus. Learn more in our guide to selank benefits.

What the Evidence Actually Shows (and Doesn't)

Bioregulator research is promising but early. Most of it is cell and animal work, the human studies are small, and nearly all of it comes from a single research network. Here is where things honestly stand.

What exists:

  • Decades of laboratory studies describing gene expression changes, peptide–DNA binding, and effects on cell aging markers.
  • Animal studies, many in rodents, examining lifespan, circadian patterns, and tissue function.
  • Human observational and small clinical studies, mostly in older adults and mostly run by Khavinson-affiliated groups.

What's missing:

  • Large, independent, randomized controlled trials published in major Western journals.
  • Consistent replication by unaffiliated labs.
  • Clear data on how much of an oral peptide reaches its target tissue intact.
  • Long-term safety data that meets modern standards.

The fair conclusion: bioregulators are a legitimate research area with a coherent theory and a large body of preliminary data. They are not proven longevity tools. Be wary of anyone who claims they will reverse aging or replace medical care. That goes beyond the evidence, and it isn't how supplements work.

Bioregulators vs. Other Peptides: Key Differences

Bioregulators differ from popular peptides like BPC-157 or GLP-1 analogs in size, proposed mechanism, and purpose. Knowing the difference helps you judge claims.

  • Size: Bioregulators are 2–4 amino acids (selank is 7). Many other peptides run from about 10 to more than 30.
  • Mechanism: Bioregulators are thought to act in the nucleus on gene expression. Most larger peptides bind cell-surface receptors.
  • Goal: Bioregulators aim to support normal, age-related tissue function over time. Many larger peptides target a single, faster-acting pathway.
  • Format: Bioregulators are commonly sold in oral forms. Many larger peptides are only stable when injected.

This is also why bioregulators have generally been studied in cycles, not continuous use. The idea is to send a periodic signal rather than to replace something the body makes. If you use a bioregulator product, follow the label directions exactly.

How to Evaluate a Bioregulator Product

Look for verified identity and purity, transparent manufacturing, and honest claims. The peptide market varies widely in quality. Many short peptides are sold online as research chemicals with no quality controls, and you have no way to confirm what's in the vial.

A practical checklist:

1. Third-party testing with a COA. A Certificate of Analysis should confirm identity and purity for the specific lot you buy. 2. Known manufacturing. Ask where the product is made and whether the facility is FDA-registered. 3. Structure/function language. Credible brands say a product "supports" or "helps maintain" function. Claims to cure, treat, or reverse conditions are a red flag. 4. Clear label directions. You should never have to guess how to use the product. 5. A real guarantee. A company that stands behind its product makes it easy to return.

At Ageless Humans, every product is made in our FDA-registered facility in Carlsbad, California. Every lot is third-party lab tested with a COA, and all products carry a 60-day money-back guarantee. Whatever brand you choose, talk with your healthcare provider before starting any peptide, especially if you're pregnant, nursing, taking medication, or managing a health condition.

Related reading & products

Frequently asked questions

What are peptide bioregulators in simple terms?+

Peptide bioregulators are very short chains of amino acids, usually 2 to 4, studied for their ability to support normal function in specific tissues. Most come from Russian gerontologist Vladimir Khavinson's research. They are thought to work by influencing gene expression inside cells rather than acting like hormones.

Who invented peptide bioregulators?+

Peptide bioregulators were developed mainly by Vladimir Khavinson and colleagues, beginning in Soviet-era research in the 1970s and continuing at the St. Petersburg Institute of Bioregulation and Gerontology. They began with peptide extracts from animal organs and later created synthetic short peptides such as epitalon. Selank, often grouped with bioregulators, was developed separately at the Institute of Molecular Genetics in Russia.

How do bioregulator peptides work?+

The leading hypothesis is that bioregulators are small enough to enter the cell nucleus and bind specific DNA sequences or histone proteins. That binding may influence which tissue-specific genes are active, supporting normal protein production as cells age. This mechanism is supported by laboratory studies but has not been broadly confirmed by independent researchers.

Is there scientific evidence that bioregulators work?+

There is a large body of cell, animal, and small human studies on bioregulators, but most comes from Khavinson-affiliated researchers. Large, independent randomized controlled trials are still lacking. The fair view is that bioregulators are a promising research area, not a proven longevity intervention.

What is the difference between epitalon, pinealon, and cartalax?+

Each is linked to a different body system. Epitalon is a four-amino-acid peptide associated with the pineal gland and studied for circadian rhythm and telomerase activity. Pinealon is a three-amino-acid peptide associated with the brain and nervous system. Cartalax is a three-amino-acid peptide associated with cartilage and connective tissue.

Are peptide bioregulators safe?+

Short peptides have been generally well tolerated in published research, but long-term safety data meeting modern standards is limited. Product quality is the bigger practical risk, because many peptides are sold online without testing. Choose third-party tested products with a COA, follow label directions, and talk with your healthcare provider first.

Keep reading